Fidelity Investments
IPSC icon

Fidelity Investments’s Century Therapeutics IPSC Stock Holding History

Fidelity Investments’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22K Buy
8,994
+215
+2% +$491 ﹤0.01% 4633
2026
Q1 		$19.8K Sell
8,779
-62,761
-88% -$132K ﹤0.01% 4517
2025
Q4 		$71.2K Sell
71,540
-120,599
-63% -$73.6K ﹤0.01% 3927
2025
Q3 		$95.7K Sell
192,139
-828,475
-81% -$447K ﹤0.01% 3682
2025
Q2 		$570K Sell
1,020,614
-1,574,131
-61% -$845K ﹤0.01% 2910
2025
Q1 		$1.24M Buy
2,594,745
+60,871
+2% +$45.7K ﹤0.01% 2607
2024
Q4 		$2.56M Buy
2,533,874
+12,363
+0.5% +$16.8K ﹤0.01% 2362
2024
Q3 		$4.31M Sell
2,521,511
-428,768
-15% -$840K ﹤0.01% 2175
2024
Q2 		$7.52M Sell
2,950,279
-420,949
-12% -$1.33M ﹤0.01% 1953
2024
Q1 		$14.1M Sell
3,371,228
-241,323
-7% -$1.02M ﹤0.01% 1774
2023
Q4 		$12M Sell
3,612,551
-912,078
-20% -$1.66M ﹤0.01% 1791
2023
Q3 		$9.05M Sell
4,524,629
-643,866
-12% -$1.71M ﹤0.01% 1850
2023
Q2 		$16.3M Sell
5,168,495
-174,488
-3% -$562K ﹤0.01% 1717
2023
Q1 		$18.5M Sell
5,342,983
-1,753,428
-25% -$7.7M ﹤0.01% 1635
2022
Q4 		$36.4M Sell
7,096,411
-131,890
-2% -$1.24M ﹤0.01% 1384
2022
Q3 		$71.5M Sell
7,228,301
-348,084
-5% -$3.67M 0.01% 1087
2022
Q2 		$63.6M Sell
7,576,385
-652,906
-8% -$6.4M 0.01% 1156
2022
Q1 		$104M Buy
8,229,291
+33,088
+0.4% +$438K 0.01% 1052
2021
Q4 		$130M Buy
8,196,203
+35,619
+0.4% +$669K 0.01% 986
2021
Q3 		$203M Buy
8,160,584
+3,201,173
+65% +$86.6M 0.02% 803
2021
Q2 		$141M Buy
+4,959,411
New +$126M 0.01% 971

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Fidelity Investments's IPSC Position: Q2 2026 in Review

Fidelity Investments increased its Century Therapeutics (IPSC) stake by 2.4% in Q2 2026, buying an estimated $491 and bringing the position to 8,994 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #4633.

Fidelity Investments first reported a position in IPSC in Q2 2021 and has held it in 21 quarters since. The position peaked at $203M in Q3 2021. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Fidelity Investments held 8,994 shares of Century Therapeutics worth $22K as of Q2 2026.
  • Fidelity Investments bought 215 Century Therapeutics shares in Q2 2026, an estimated $491.
  • Century Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4633 holding.
  • Fidelity Investments first reported a position in Century Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Fidelity Investments's Century Therapeutics position peaked at $203M in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.